|
|
DAY 1 MORNING SESSION��
OUTSOURCING OUTLOOK & CHALLENGES
| 7:00 �C 9:00 |
Conference Registration |
| 9:00 �C 9:10 |
Welcome Remarks by the Organizer
��Ms. Huifang Wu, General Manager, Healthoo.Com (China) |
| 9:10 �C 9:40 |
Program Chairman��s Introductory Remarks
��Dr. James Chen, President, Agno Pharma (USA) |
| 9:40 �C 10:25 |
��Change in the Pharma Industry- What it Means for the Supply Chain
��Dr. Simon Sellers, CEO, Bioavailability Systems LLC (USA) |
| 10:25 �C 10:40 |
Networking Break |
| 10:40 �C 12:00 |
��Case Studies, Panel Discussion, Questions & Answers |
| |
��Case 1: Challenges in Manufacturing Drugs in China:��The Baxter Heparin Episode��
��Dr. Max Zive, President, Zipharm International Inc. (Canada)
��Case 2: Status of CRO/CMO in China: A US Returnee Perspective
��Dr. Wayne Li, Project Manager, Morningside Technologies (HK)
��Panel Discussion: Outsourcing Outlook & Challenges
��Panelists: Dr. Simon Sellers, Dr. Max Zive & Dr. Wayne Li |
| 12:00�C13:30 |
Networking Lunc |
| DAY 1 AFTERNOON SESSION����
OUTSOURCING BY GENERIC PHARMA COMPANIES |
| 13:30 - 14:15 |
��Introducing generic APIs to the Highly Competitive North American Market
��Mr. Aviv Laor, Director, AZAD Fine Chemicals (Switzerland) |
| 14:15 �C 5:00 |
Canadian Client Expectations in Sourcing Generic API��s
��Dr. Max Zive, President, Zipharm International Inc. (Canada) |
| 15:00 �C 5:15 |
Networking Break |
| 15:15 �C16:00 |
Generic Drug Development �C Life Cycle and Patent Game
��Dr. Lee Kang, Director, Perrigo Company |
| 16:00 �C17:00 |
Panel Discussion, Questions & Answers |
| |
��Topic 1: Perception of Chinese API suppliers by North American clients
��Topic 2: Is China ready to enter the highly competitive North American dosage form market?
|
| 18:00 |
Complimentary Networking Dinner |
| DAY 2 MORNING SESSION ��
OUTSOURCING BY ETHICAL PHARMA COMPANIES |
| 9:00 �C 9:30 |
Program Chairman��s Introductory Remarks
��Dr. James Chen, President, Agno Pharma (USA) |
| 9:30 �C 10:15 |
he Role of China in Drug Discovery in the 21st Century: A View From the Starting Gate
��Dr. Kerry Spear, Executive Director, Sepracor Corporation (USA)
|
| 10:15 �C 10:30 |
Networking Break |
| 10:30 �C 11:15 |
Contracting with Indian and Chinese CROs �C Challenges and Opportunities
��Dr. Jay Reddy, Vice President, Sai Advantium Pharma Limited (USA & INDIA) |
| 11:15 �C 12:00 |
Panel Discussion, Questions & Answers
��Panelists: Dr. Kerry Spear, Dr. Jay Reddy & Dr. Simon |
| |
��Topic 1: Timing for true drug discovery in China
��Topic 2: China vs India: strengths & weakness
|
| 12:00�C13:30 |
Networking Lunch |
| DAY 2 AFTERNOON SESSION��
OUTSOURCING BY ETHICAL PHARMA COMPANIES |
| 13:00 �C 13:45 |
��Outsourcing Clinical APIs: Is China Ready?
��Dr. James J. Chen, President, Agno Pharma (USA) |
| 14:15 �C 15:00 |
��Intellectual Property Issues in Outsourcing - Measures to Lower IP Risks But Increase Business Opportunities.
��Dr. James J. Zhu, Partner, Perkins Coie LLP (USA) |
| 15:00 �C 15:20 |
��Networking Break |
| 15:20�C 17:00 |
��Panel Discussion, Questions & Answers
��Panelists: Dr. James J. Chen, Dr. James J. Zhu |
| |
��Topic: Status & legal concerns of US Pharma companies in outsourcing high IP protection projects/products to China |
| 18:00 |
Conference Adjourn |
|
|
|
